Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Doering

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Discovery|June 1, 2012
Fluorescence lifetime assays: current advances and applications in drug discoveryStephan Pritz, Klaus Doering, Julian Woelcke, et al.
Journal of Biomolecular Screening|January 28, 2009
A fluorescence lifetime-based assay for protease inhibitor profiling on human kallikrein 7Klaus Doering, Gabriele Meder, Manuela Hinnenberger, et al.
The Journal of Biological Chemistry|February 16, 2006
The crystal structure of H-2D(b) complexed with a partial peptide epitope suggests a major histocompatibility complex class I assembly intermediateAnn Glithero, Jose Tormo, Klaus Doering, et al.
Journal of Biomolecular Screening|December 15, 2010
A fluorescence lifetime-based assay for abelson kinaseStephan Pritz, Gabriele Meder, Klaus Doering, et al.
Assay and Drug Development Technologies|January 28, 2006
Multiparameter analysis of a screen for progesterone receptor ligands: comparing fluorescence lifetime and fluorescence polarization measurementsBryan D Marks, Naveeda Qadir, Hildegard C Eliason, et al.
Assay and Drug Development Technologies|October 12, 2018
A Comparative Study of Fluorescence Assays in Screening for BRD4Pia Hansson, Helen Boyd, Ian L Dale, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Discovery|June 1, 2012
Fluorescence lifetime assays: current advances and applications in drug discoveryStephan Pritz, Klaus Doering, Julian Woelcke, et al.
Journal of Biomolecular Screening|January 28, 2009
A fluorescence lifetime-based assay for protease inhibitor profiling on human kallikrein 7Klaus Doering, Gabriele Meder, Manuela Hinnenberger, et al.
The Journal of Biological Chemistry|February 16, 2006
The crystal structure of H-2D(b) complexed with a partial peptide epitope suggests a major histocompatibility complex class I assembly intermediateAnn Glithero, Jose Tormo, Klaus Doering, et al.
Journal of Biomolecular Screening|December 15, 2010
A fluorescence lifetime-based assay for abelson kinaseStephan Pritz, Gabriele Meder, Klaus Doering, et al.
Assay and Drug Development Technologies|January 28, 2006
Multiparameter analysis of a screen for progesterone receptor ligands: comparing fluorescence lifetime and fluorescence polarization measurementsBryan D Marks, Naveeda Qadir, Hildegard C Eliason, et al.
Assay and Drug Development Technologies|October 12, 2018
A Comparative Study of Fluorescence Assays in Screening for BRD4Pia Hansson, Helen Boyd, Ian L Dale, et al.
Pageof 1